I-Roflumilast CAS 162401-32-3 Assay 99.0~101.0% API
I-Ruifu Chemical Supply Roflumilast Intermediates:
I-Roflumilast CAS 162401-32-3
4-Amino-3,5-Dichloropyridine CAS 22889-78-7
Igama Lekhemikhali | I-Roflumilast |
Omqondofana | 3-(Cyclopropylmethoxy)-N-(3,5-Dichloropyridin-4-yl)-4-(Ddifluoromethoxy)benzamide |
Inombolo ye-CAS | 162401-32-3 |
Inombolo yeCAT | I-RF-PI2075 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C17H14Cl2F2N2O3 |
Isisindo samangqamuzana | 403.21 |
Ukuminyana | 1.471±0.060 g/cm3 |
Ukuzwela | Ukushisa Kuyazwela |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | I-Crystalline Powder Emhlophe noma Cishe Emhlophe |
Ukuncibilika | I-soluble yamahhala ku-acetone, inyibilika kancane ku-acetronitrile, ayincibiliki kancane ku-ethanol e-anhydrous, cishe ayincibiliki emanzini. |
I-Melting Point | 157.0~162.0℃ |
Ukulahlekelwa Ekumisweni | <0.50% |
Izinsalela ekushiseni | ≤0.10% |
Izinsimbi Ezisindayo | ≤10ppm |
I-Chloride | ≤0.01% |
Ukuhlonza A. UV | Ubude begagasi bokumuncwa okuphezulu kufanele bube ku-213~251nm |
Ukuhlonza B. IR | I-spectrum yokumuncwa kwe-IR yesampula ihambisana naleyo yereferensi |
Ukuhlonza C. | Ibonisa ukusabela kweFluoride |
Izinto Ezihlobene | |
Ukungcola Okukodwa | ≤0.10% |
Ukungcola Okuphelele | <0.50% |
Izincibilikisi Ezisele | |
I-Tert-Butanol | <0.10% |
I-Tetrahydrofuran | <0.072% |
I-Toluene | <0.089% |
I-N, N-Dimethylformamide | <0.088% |
Isivivinyo | 99.0~101.0% (Ibalwe Ngesisekelo Esomisiwe) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-API;I-COPD |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-Roflumilast (i-CAS: i-162401-32-3) i-oral phosphodiesterase-4 (PDE-4) inhibitor ekhethiwe kanye ne-benzamide compound.Yasungulwa yinkampani yaseJalimane i-Altana ngo-1993 futhi iyona kuphela inhibitor yomlomo ye-PDE-4 esetshenziselwa ukwelapha izifo zemigudu yokuphefumula evunyelwe ukudayiswa.I-Roflumilast umuthi wokuqala wohlobo lwayo ukukhomba isifo esiyingozi esingalapheki esivimbela amaphaphu (COPD), futhi iphinde ibe umuthi wokuqala womlomo wokulwa nokuvuvukala owenzelwe iziguli ezine-COPD.Izakhiwo zayo eziyingqayizivele zingasiza ekulawuleni i-COPD: uma isetshenziswa ngokuhambisana nama-bronchodilator ekwelapheni iziguli ezinzima kakhulu ze-COPD, i-Roflumilast ingaba nenzuzo yokuqhubeka nokunciphisa izimpawu kanye nezinga lokuwohloka, ngaleyo ndlela iyenze ibe umuthi wokuqala oqondiswe ezigulini ezine-phenotype-spAecific COPD ewohlokayo eqhubekayo. kanye nokuphazamiseka okukhulu kokugeleza komoya okuhlobene nokukhwehlela okungapheli kanye ne-phlegm eyeqile.Ngaphandle kokuba ukwelashwa kwe-COPD enzima, i-Roflumilast ingase futhi isetshenziselwe ukuvimbela nokwelapha izifo zepheshana lokuphefumula kwemfuyo, ukukhwehlela okweqile kwe-mucosa bronchitis, i-asthmatic bronchitis, ne-acute bronchitis kanye ne-air sacculitis ehambisana nokuphuma kwepheshana lokuphefumula okungavamile.